27/H/Inj.Dulaglutide 1.5mg/26-27
All India Institute of Medical Sciences · New Delhi, Delhi · Pharmaceuticals · open
Key facts
- EMD: ₹50K
- Published: 10 Nov 2026
- Closing date: 02 Dec 2026
- Status: open
- Status as of: 14 Nov 2026 04:18 UTC
- Office: Hospital Store (Main), AIIMS New Delhi
Description
Procurement of Inj. Dulaglutide 1.5mg through a two-year rate contract for AIIMS New Delhi and its centres. Bids are invited from eligible manufacturers or sole importers.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
- Documents required: EMD/Bid Security or documentary evidence for exemption, List of Items Quoted, Tender Acceptance Form, GST Registration Certificate, Power of Attorney in favor of bid signatory, Documents establishing bidder eligibility and qualification, Documents establishing conformity of goods to tender requirements, Documents confirming sole proprietorship, partnership, or private limited firm status in country of origin, as applicable, Undertakings and other documents as required by the Tender Enquiry Document, Price Schedule (BOQ) with details including make and model
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two bid system (Techno-Commercial Bid and Financial Bid)
- Make in India (MII): No
- MSE preference: No
Line items (1)
- Inj. Dulaglutide 1.5mg — Qty: 1 per Inj
2 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Supply of veterinary medicines, blood collection tubes and syringes — Pharmaceuticals · Jammu and Kashmir · ₹75K
- Supply of Veterinary Injections — Pharmaceuticals · Jammu and Kashmir · ₹75K
- Supply of medicines, medical consumables and medical equipment — Pharmaceuticals · Jammu and Kashmir